More symptomatic upper GI events with rofecoxib than celecoxib

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1072卷 / 1期

关键词：

Primary Care; Celecoxib; Rate Ratio; Thromboembolic Event; Rofecoxib;

D O I：

10.2165/00128415-200510720-00009

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[41] More endoscopists improve outcome for upper GI cancer
不详
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) : 1174 - 1174
[42] Catheter ablation did not reduce CV events and mortality more than drug therapy in symptomatic AF
Santulli, Gaetano
ANNALS OF INTERNAL MEDICINE, 2019, 171 (02) : JC8 - JC10
[43] Treatment with rofecoxib required less gastrointestinal (GI) co-medication and fewer GI procedures than nonspecific cyclooxygenase inhibitors (NSAIDs).
Watson, DJ
Harper, S
Zhao, P
Bolognese, J
Simon, T
Seidenberg, B
ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S403 - S403
[44] Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study
Bjorn Gudbjornsson
Sigurdur B. Thorsteinsson
Helgi Sigvaldason
Rannveig Einarsdottir
Magnus Johannsson
Helga Zoega
Matthias Halldorsson
Gudmundur Thorgeirsson
European Journal of Clinical Pharmacology, 2010, 66 : 619 - 625
[45] Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib
Goldstein, JL
JOURNAL OF RHEUMATOLOGY, 2000, 27 : 25 - 28
[46] Incidence of upper GI perforations, ulcers, and bleeding (PUBs) in the phase III rofecoxib rheumatoid arthritis database
DeTora, LM
Truitt, KE
Bolognese, JA
Sperling, RS
Watson, DJ
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S174 - S174
[47] Less upper GI damage with etoricoxib than other NSAIDs
Reactions Weekly, 2005, 1058 (1) : 4 - 4
[48] Fewer GI adverse events with meloxicam than comparator NSAIDs
Reactions Weekly, 2000, 792 (1) : 4 - 4
[49] Diagnostic upper GI endoscopy: can less mean more?
Penman, Ian
GUT, 2024, 73 (09) : 1405 - 1406
[50] The FODMAP diet: more than just a symptomatic therapy?
Gibson, Peter R.
Halmos, Emma P.
GUT, 2022, 71 (09) : 1693 - 1694

← 1 2 3 4 5 →